Funds and ETFs Clover Biopharmaceuticals, Ltd.
Equities
2197
KYG2280A1076
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 HKD | 0.00% | -6.38% | -29.03% |
Apr. 12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
Apr. 08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
ETFs positioned on Clover Biopharmaceuticals, Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.69% | 4 M€ | -27.92% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.03% | 73.12M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.39% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- 2197 Stock
- Funds and ETFs Clover Biopharmaceuticals, Ltd.